Related Experiment Video
Updated: Jan 16, 2026

07:01
Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors
Published on: March 1, 2020
10.8K
Investigating Germ Cell Transition Genes in Breast Cancer: Exploring the Genesis of Cancer Testis-Associated Markers
Hamid Khodayari1,2, Saeed Khodayari1,2, Mohammad Dashtkoohi1
1Cancer Research Center, Cancer Institute of Iran, Tehran University of Medical Sciences, Tehran 1419733141, Iran.
International Journal of Molecular Sciences
|September 27, 2025
Summary
Breast cancer cells can exhibit male germ cell features, with 455 overexpressed genes identified. This transition, involving specific genes like CCNB1, may originate from tumor stromal cells.
Area of Science:
- Oncology
- Developmental Biology
- Genetics
Background:
- Cellular transition is crucial for tumorigenesis and phenotype development.
- Testis cancer antigens (TCAs) in breast carcinomas hint at potential male germ cell transitions.
Purpose of the Study:
- To investigate breast cancer cells expressing male germ cell development genes.
- To identify germline-associated genes within breast tumors and analyze cellular heterogeneity.
Main Methods:
- Re-analysis of published datasets to identify germline-associated genes.
- Quantitative RT-PCR validation in 28 breast tumor samples.
- Single-cell RNA sequencing (scRNA-seq) for tumor heterogeneity and cell clustering analysis.
Main Results:
- Identified 455 overexpressed genes linked to fetal primordial germ cells (PGCs), especially male gonad PGCs.
- Found significant overexpression of five genes (CCNB1, CCNB2, PTTG1, RACGAP1, UBE2C) in tumor samples.
- scRNA-seq revealed 14 distinct cell clusters with varied gene expression and cell cycle phases; breast tumor stromal cells implicated as the source.
Conclusions:
- Breast cancer exhibits characteristics of male germ cell transition.
- Stromal cells within breast tumors are a likely source of germline-associated genes.
- This study offers insights into molecular pathways of germ cell transition in breast carcinoma.

